FAIRFIELD, Iowa, December 13, 2017 — Hedge Funds gained 0.62% in November according to the Barclay Hedge Fund Index compiled by BarclayHedge. The index is up 9.08% in 2017, and has had 13 consecutive winning months during which it gained 11.20% return.
“The possibility that the US Senate might pass a tax bill rallied domestic equity markets,” says Sol Waksman, founder and president of BarclayHedge. “For each of the past 13 months, the monthly close of the S&P 500 has set a new record high.”
Once again, the Technology Index powered upward with a 3.63% return in November. Technology has had 12 months of gains in the past 13 months, and is now up 25.29% for the year.
The Healthcare and Biotechnology Index bounced back from a 1.57% loss in October with a 2.98% gain in November. Equity Long Bias was up 1.63%, Emerging Markets added 0.64%, Distressed Securities were up 0.59%, and Pacific Rim Equities rose 0.33%.
Eight hedge fund indices lost ground in November. The Merger Arbitrage Index was down 0.79%, European Equities gave up 0.57%, Fixed Income Arbitrage lost 0.30%, and Convertible Arbitrage slid 0.21%.
All of Barclay’s 17 hedge fund indices are profitable after eleven months. Following the strong performance of the Technology Index, Healthcare & Biotechnology is up 18.70% for the year, Emerging Markets have gained 16.40%, Pacific Rim Equities are up 13.18%, and the Equity Long Bias Index has added 12.67%.
The Barclay Fund of Funds Index lost 0.03% in November, but is up 5.66% for the year.
For a complete table of BarclayHedge Hedge Fund Index and Sub–Index performance, click here.
Sol Waksman is the founder and president of BarclayHedge. Waksman is an industry expert and experienced media source, providing perspectives on hedge fund and managed futures trends.
BarclayHedge is the global leader in providing independent, research-based information services to the alternative investment industry. Founded in 1985, Barclay currently maintains data on more than 6,600 hedge funds, fund of funds, and CTAs. No one has been in the business of collecting alternative investment data longer than BarclayHedge.
Institutional investors, brokerage firms, and private banks worldwide utilize BarclayHedge indices as performance benchmarks for the hedge fund and managed futures industries.